IE45338B1 - Composition for treating leukemia and ascites tumour - Google Patents

Composition for treating leukemia and ascites tumour

Info

Publication number
IE45338B1
IE45338B1 IE485/77A IE48577A IE45338B1 IE 45338 B1 IE45338 B1 IE 45338B1 IE 485/77 A IE485/77 A IE 485/77A IE 48577 A IE48577 A IE 48577A IE 45338 B1 IE45338 B1 IE 45338B1
Authority
IE
Ireland
Prior art keywords
deazaminopterin
composition
dosage
ils
tumour
Prior art date
Application number
IE485/77A
Other languages
English (en)
Other versions
IE45338L (en
Original Assignee
Stanford Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Research Inst filed Critical Stanford Research Inst
Publication of IE45338L publication Critical patent/IE45338L/xx
Publication of IE45338B1 publication Critical patent/IE45338B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IE485/77A 1976-03-05 1977-03-04 Composition for treating leukemia and ascites tumour IE45338B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66421376A 1976-03-05 1976-03-05

Publications (2)

Publication Number Publication Date
IE45338L IE45338L (en) 1977-09-05
IE45338B1 true IE45338B1 (en) 1982-08-11

Family

ID=24665062

Family Applications (1)

Application Number Title Priority Date Filing Date
IE485/77A IE45338B1 (en) 1976-03-05 1977-03-04 Composition for treating leukemia and ascites tumour

Country Status (10)

Country Link
JP (1) JPS52120134A (fr)
AU (1) AU511856B2 (fr)
BE (1) BE852095A (fr)
CA (1) CA1085729A (fr)
DE (1) DE2709506C2 (fr)
FR (1) FR2342732A1 (fr)
GB (1) GB1534238A (fr)
IE (1) IE45338B1 (fr)
IL (1) IL51593A (fr)
ZA (1) ZA771315B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393064A (en) * 1976-03-05 1983-07-12 Sri International Process and composition for treatment of leukemia and process for preparing the same
US4460591A (en) * 1982-08-26 1984-07-17 Sri International 8,10-Dideazaminopterins
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
US5026851A (en) * 1985-03-08 1991-06-25 The Trustees Of Princeton University Pyrido[2,3-]pyrimidine derivatives
US4833145A (en) * 1986-06-30 1989-05-23 The Trustees Of Princeton University 4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
US4902796A (en) * 1986-10-20 1990-02-20 The Trustees Of Princeton University 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
US4996206A (en) * 1989-12-11 1991-02-26 The Trustees Of Princeton University N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
US6358953B1 (en) * 1998-10-22 2002-03-19 Phillip B. B. Moheno Pterin antineoplastic agents

Also Published As

Publication number Publication date
CA1085729A (fr) 1980-09-16
IL51593A (en) 1980-01-31
IL51593A0 (en) 1977-05-31
AU2292677A (en) 1978-09-07
ZA771315B (en) 1978-05-30
DE2709506A1 (de) 1977-09-08
JPS613325B2 (fr) 1986-01-31
IE45338L (en) 1977-09-05
AU511856B2 (en) 1980-09-11
GB1534238A (en) 1978-11-29
DE2709506C2 (de) 1987-03-26
BE852095A (fr) 1977-07-01
FR2342732B1 (fr) 1980-02-01
JPS52120134A (en) 1977-10-08
FR2342732A1 (fr) 1977-09-30

Similar Documents

Publication Publication Date Title
US5114951A (en) Agents for combating multiple drug resistance
US8299078B2 (en) Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin
CN101360495B (zh) 对癌症病人给药mTOR抑制剂
EP0944389B1 (fr) Compositions purifiees de 10-propargyl-10-deazaaminopterine et leur methodes d'utilisation pour le traitement de tumeurs
IE45338B1 (en) Composition for treating leukemia and ascites tumour
US20250152569A1 (en) Treatment of cell proliferation-associated conditions using a combination of a clb-b inhibitor and an additional therapeutic agent
TW201922256A (zh) 治療淋巴樣惡性疾病之方法
EP1839662B1 (fr) Agent antitumoral
US20030096852A1 (en) Human growth hormone antagonists
EP0758549A1 (fr) Composition medicinale servant de medicament contre le cancer bronchopulmonaire "non a petites cellules"
EP1662874A2 (fr) Co-administration de polysaccharide avec un agent chimiotherapeutique pour le traitement du cancer
NZ760233A (en) Compositions and methods for treatment of abnormal cell growth
CN101429201A (zh) 柠檬酸小檗胺盐及制备方法和应用
Hellmann et al. Radiotherapeutic enhancement by razoxane
US20090281105A1 (en) Radiotherapy enhancer
CN101185627B (zh) 一种治疗实体肿瘤的尼罗替尼缓释植入剂
US20050065122A1 (en) Taurine compounds
US7928102B2 (en) Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam
US4005204A (en) Treatment of neoplasms in the brain with diamino dichloroalkyl pyrimidine
US4006235A (en) Treating CNS lymphoma
US4005203A (en) Treatment of meningeal leukemia with diamino dichlorophenyl pyrimidine
KR101767602B1 (ko) N-페닐피리미딘-2-아민계 화합물, 이의 제조방법, 이를 포함하는 암 예방 및 치료용 약학 조성물 및 이를 이용한 암 예방 또는 암 치료 방법
US3291688A (en) Anthelmintic tetrahydropyrimidines
US4329346A (en) Pharmaceutical compositions containing 2,6-bis-(diethanolamino)-4-piperidino-pyrimido[5,4-d]pyrimidine
JPH0120128B2 (fr)

Legal Events

Date Code Title Description
MK9A Patent expired